Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2023

Open Access 01-12-2023 | Correction

Correction: L-Arginine in diabetes: clinical and preclinical evidence

Authors: Imma Forzano, Roberta Avvisato, Fahimeh Varzideh, Stanislovas S. Jankauskas, Angelo Cioppa, Pasquale Mone, Luigi Salemme, Urna Kansakar, Tullio Tesorio, Valentina Trimarco, Gaetano Santulli

Published in: Cardiovascular Diabetology | Issue 1/2023

Login to get access

Excerpt

Correction: Cardiovascular Diabetology (2023) 22:89
Literature
Metadata
Title
Correction: L-Arginine in diabetes: clinical and preclinical evidence
Authors
Imma Forzano
Roberta Avvisato
Fahimeh Varzideh
Stanislovas S. Jankauskas
Angelo Cioppa
Pasquale Mone
Luigi Salemme
Urna Kansakar
Tullio Tesorio
Valentina Trimarco
Gaetano Santulli
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2023
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-023-01852-1

Other articles of this Issue 1/2023

Cardiovascular Diabetology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine